Skip to main content

Enzyme substitution by fibroblast transplantation

  • Chapter
Inborn Errors of Metabolism in Humans
  • 77 Accesses

Abstract

The first inborn error of metabolism to be recognized was alcaptonuria, described by Garrod in 19081. He developed the concept that some diseases occur because an enzyme which controls a single metabolic step is entirely absent or has a greatly reduced activity. More than 330 such disorders have now been described2, more than 30 of which are lysosomal storage diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Garrod, A. E. (1908). Inborn errors of metabolism. Croonian Lectures. Lancet, 2, 1

    Article  CAS  Google Scholar 

  2. Stanbury, J. B., Wyngaarden, J. B. and Fredrickson, D. S. (1978). The Metabolic Basis of Inherited Disease, p. 14. (NewYork: McGraw Hill)

    Google Scholar 

  3. Neuwelt, E., Stumpf, D., Austin, J. and Kohler, P. (1971). A monospecific antibody to human sulphatase A. Biochim. Biophys. Acta, 236, 333

    PubMed  CAS  Google Scholar 

  4. Mersmann, G. and Buddecke, E. (1977). Evidence from mannosidosis fibroblasts cross reacting with anti-acidic α-mannosidase antibodies. FEBS Lett., 73, 123

    Article  PubMed  CAS  Google Scholar 

  5. Bell, C. E. Jr., Sly, W. S. and Brot, F. E. (1977). Human β-glucuronidase deficiency mucopolysaccharidosis: identification of cross-reactive antigen in cultured fibroblasts of deficient patients by primary enzyme immunoassay, J. Clin. Invest., 59, 97

    Article  PubMed  CAS  Google Scholar 

  6. Di Ferrante, N., Nichols, B., Donnelly, P. V., Neri, G., Hrgovcic, R. and Berglund, R. K. (1971). Induced degradation of glycosaminoglycans in Hurler’s and Hunter’s syndromes by plasma infusion. Proc. Natl. Acad. Sci. USA, 68, 303

    Article  PubMed  Google Scholar 

  7. Dean, M. F., Benson, P. F. and Muir, H. (1973) Mobilisation of glycosaminoglycans by plasma infusions in mucopolysaccharidosis type III - Two types of response. Nature (London) New Biol., 243, 143.

    CAS  Google Scholar 

  8. Dean, M. F. Benson, P. F. and Muir, H. (1975). Differing patterns of glycosaminoglycan mobilisation in Sanfilippo and Hunter Syndromes following infusion of normal plasma. In Proceedings of the 3rd International Congress for the Scientific Study of Mental Deficiency, p. 270. (The Hague: International Association for the Scientific Study of Mental Deficiency)

    Google Scholar 

  9. Knudson, A. G., Di Ferrante, N. and Curtis, J. E. (1971). Effect of leucocyte transfusion in a child with type II mucopolysaccharidosis. Proc. Natl. Acad. Sci. USA, 68, 1738

    Article  PubMed  Google Scholar 

  10. Moser, H. W., O’Brien, J. S., Atkins, L., Fuller, T. C., Keiman, A., Janowska, S., Russell, P. F., Bartsocas, C. S., Cosimi, B. and Dulaney, J. T. (1974). Infusion of normal HLA identical lymphocytes in Sanfilippo disease type B. Arch. Neurol., 31, 329

    PubMed  CAS  Google Scholar 

  11. Brady, R. O., Tallman, J. F., Johnson, W. G., Gal, A. E., Leahy, W. R., Quick, J. M. and Dekaban, A. S. (1973). Replacement thrapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry’s disease. N. Engl. J. Med., 289, 9

    Article  PubMed  CAS  Google Scholar 

  12. Gregoriadis, G. (1979). Liposomes. In Gregoriadis, G. (ed.) Drug Carriers in Biology and Medicine, pp. 287-341 (London: Academic Press)

    Google Scholar 

  13. Clarke, J. T. R., Guttman, R. D., Wolfe, L. S., Beaudoin, J. G. and Morehouse, D. D, (1972). Enzyme replacement therapy by renal allotransplantation in Fabry’s disease. N. Engl. J. Med., 287, 1215

    Article  PubMed  CAS  Google Scholar 

  14. Philippart, M., Franklin, S. S. and Gordon, A. (1972). Reversal of an inborn sphingolipidosis (Fabry’s disease) by kidney transplantation. Ann. Int. Med., 77, 195

    PubMed  CAS  Google Scholar 

  15. Dean, M. F., Muir, H. Benson, P. F., Button, L. R. Batchelor, J. P. and Bewick, M. (1975). Increased breakdown of glycosaminoglycans and increased appearance of corrective enzyme after skin transplants in Hunter Syndrome. Nature (London), 257, 609

    Article  PubMed  CAS  Google Scholar 

  16. Dean, M. F., Stevens, R. L. Muir, H., Benson, P. F., Button L R Anderson, R. L., Boylston, A. and Mowbray, J. (1979). Enzyme replacement therapy by fibroblast transplantation. Long-term biochemical study in 3 cases of Hunter’s Syndrome. J. Clin. Invest., 63, 138

    Article  PubMed  CAS  Google Scholar 

  17. Dean, M. F., Muir, H., Benson, P. F., Button, L. R. (1980). Enzyme replacement therapy in the Mucopolysaccharidoses by fibroblast transplantation. In Birth Defects. Original Article Series Vol. XVI No 1, p 445 (USA: March of Dimes Birth Defects Foundation)

    Google Scholar 

  18. Gibbs, D. A., Spellacy, E., Roberts, A. E. and Watts, R. W. E. (1980). The treatment of lysosomal storage diseases by fibroblast transplantation: Some preliminary observations. In Birth Defects: Original Article Series Vol. XVI, No. 1, p. 457 (USA: March of Dimes Birth Defects Foundation)

    Google Scholar 

  19. von Figura, K., and Kresse, H. (1974). Quantitative aspects of pinocytosis and the intracellular fate of N-acetyl-α-D-glucosaminidase in Sanfilippo B fibroblasts. J. Clin. Invest., 53, 85

    Article  Google Scholar 

  20. Sando, G. N. and Neufeld, E. F. (1977). Recognition and receptor mediated uptake of a lysosomal enzyme, α-L-iduronidase by cultured human fibroblasts. Cell, 12, 619

    Article  PubMed  CAS  Google Scholar 

  21. Ullrich. K., Mersmann, G., Weber, E. and von Figura, K. (1978). Evidence lor lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem. J., 170, 643

    PubMed  CAS  Google Scholar 

  22. Rome, L. H., Garvin, A. J., Allietta, M. M. and Neufeld, E. F. (1979). Two species of lysosomal organelles in cultured human fibroblasts. Cell, 17, 143

    Article  PubMed  CAS  Google Scholar 

  23. Dean, M. F., Benson, P. F. and Muir, H. (1975). The effect of dextran infusions on glycosaminoglycan excretion in the Sanfilippo Syndrome. Devel. Med. Child. Neurol., 17, 47

    Article  CAS  Google Scholar 

  24. O’Brien, J. S., Miller, A. L., Loverde, A. W. and Veath, M. L. (1973). Sanfilippo disease type B: Enzyme replacement and metabolic correction in cultured fibroblasts. Science, 187, 753

    Article  Google Scholar 

  25. Barton, R W. and Neufeld, E. F. (1971). The Hurler corrective factor: Purification and some properties. J. Biol. Chem 246, 7773

    PubMed  CAS  Google Scholar 

  26. Kresse, H. and Neufeld, E. F. (1972). The Sanfilippo A corrective factor: Purification and mode of action. J. Biol Chem., 247, 2164

    PubMed  CAS  Google Scholar 

  27. Cantz, M., Chrambach, A., Bach, G. and Neufeld, E. F. (1972). The Hunter corrective factor: Purification and preliminary characterisation. J. Biol. Chem., 247, 5456

    PubMed  CAS  Google Scholar 

  28. Bach, G. and Liebmann-Eisenberg, A. (1979) Intracellular localization of exogenous β-glucuronidase in cultured skin fibroblasts. Eur. J. Biochem., 96, 613

    Article  PubMed  CAS  Google Scholar 

  29. Fratantoni, J C., Hall, C. W. and Neufeld, E. F. (1968). Hurler and Hunter Syndromes. Mutual corrections of the defect in cultured fibroblasts. Science (Wash.), 162, 500

    Article  Google Scholar 

  30. Fratantoni, J. C., Hall, C. W. and Neufeld, E. F. (1969). The defect in Hurler and Hunter Syndromes. II Deficiency of specific factors involved in mucopolysaccharide degradation. Proc. Natl. Acad. Sci. USA 64, 360

    Article  PubMed  CAS  Google Scholar 

  31. Rome, L. H., Garvin, A. J., Allietta, M. M. and Neufeld, E. F (1979) Two species of lysosomal organelles in cultured human fibroblasts Cell 17, 143

    Article  PubMed  CAS  Google Scholar 

  32. McKusick, V. A. (1972). Heritable Disorders of Connective tissues, p. 556. (St. Louis: Mosby)

    Google Scholar 

  33. Kresse, H. (1973). Mucopolysaccharidosis IIIA (Sanfilippo A Disease): A deficiency of a heparin sulphamidase in skin fibroblasts and leucocytes. Biochem. Biophys. Res. Commun., 54, 1111

    Article  PubMed  CAS  Google Scholar 

  34. Bach, G., Eisenberg, F. Jr., Cantz, M. and Neufeld, E. F (1973). The defect in the Hunter Syndrome: Deficiency of sulphoiduronate sulphatase. Proc. Natl. Acad. SCi. USA, 70, 2134

    Article  PubMed  CAS  Google Scholar 

  35. Bitter, T. and Muir, H. (1962). A modified uronic acid carbazole reaction. Anal. Biochem., 4, 330

    Article  PubMed  CAS  Google Scholar 

  36. Kraan, J. and Muir, H. (1957). The determination of glucosamine. Biochem. J., 66, 55

    Google Scholar 

  37. Ginsberg, L. C. and Di Ferrante, N. (1977). Sensitive method for the determination of ester sulphate in biological systems. Biochem. Med., 17, 80

    Article  PubMed  CAS  Google Scholar 

  38. Lagunoff, D. and Warren, G. (1962). Determination of 2-deoxy-2-sulph-aminohexose content of mucopolysaccharides. Arch. Biochem. Biophys., 99, 396

    Article  PubMed  CAS  Google Scholar 

  39. Lim, T. W., Leder, I. G., Bach, G. and Neufeld, E. F. (1974). Assay for iduronate sulphatase. Carbohydr. Res., 37, 103

    Article  PubMed  CAS  Google Scholar 

  40. Liebaers, I. and Neufeld, E. F. (1976). Iduronate sulphatase activity in serum, lymphocytes and fibroblasts - simplified diagnosis of the Hunter Syndrome, Pediatr. Res., 10, 733

    PubMed  CAS  Google Scholar 

  41. Bach, G., Friedmann, R., Weismann, B. and Neufeld, E. F. (1972). The defect in Hurler and Scheie Syndromes. Deficiency of α-L-iduronidase. Proc. Natl. Acad. SCi. USA, 69, 2084

    Article  Google Scholar 

  42. Kaplan, A., Achord, D. T. and Sly, W. S. (1977). Phosphohexosyl components of a lysosomal enzyme are recognised by pinocytosis receptors on human fibroblasts. Proc. Natl. Acad. Sci. USA., 74, 2026

    Article  PubMed  CAS  Google Scholar 

  43. Sando, G. N. and Neufeld, E. F. (1977). Recognition and receptor mediated uptake of a lysosomal enzyme, α-L-iduronidase by cultured human fibroblasts. Cell, 12, 619

    Article  PubMed  CAS  Google Scholar 

  44. Feder, N. (1976). Solitary cells and enzyme exchange in tetraparental mice. Nature (London), 263, 66

    Article  Google Scholar 

  45. Jolly, R. D., Thompson, K. G., Murphy, C. E., Manktelow, B. W., Bruere, A. M. and Winchester, B. G. (1976). Enzyme replacement therapy-an experiment in nature in a clinical mannosidosis calf. Pediatr. Res., 10, 219

    PubMed  CAS  Google Scholar 

  46. Kihara, H., Porter, M. and Fluharty, A. (1973). In Birth Defects, Original Article Series, Vol. 9, pp. 19-26, National Foundation March of Dimes. (New York: Williams and Wilkins)

    Google Scholar 

  47. Mersmann, G. and Buddecke, E. (1976). Storage of Mannose containing material in cultured human mannosidosis cells and metabolic correction by pig kidney α-mannosidase. Hoppe-Seyler’s Z. Physiol. Chem., 357, 641

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 The Society for the Study of Inborn Errors of Metabolism

About this chapter

Cite this chapter

Dean, M.F., Muir, H., Benson, P.F., Button, L.R. (1982). Enzyme substitution by fibroblast transplantation. In: Cockburn, F., Gitzelmann, R. (eds) Inborn Errors of Metabolism in Humans. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7325-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7325-1_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7327-5

  • Online ISBN: 978-94-009-7325-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics